myeloproliferative disease

Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations
Yen-Chun Liu, Gwendolyn M Illar, Nathanael Glen Bailey

Journal of Clinical Pathology Nov 2020, 73 (11) 728-736; DOI: 10.1136/jclinpath-2020-206495
Chronic neutrophilic leukaemia
Guldeep Uppal, Jerald Gong

Journal of Clinical Pathology Sep 2015, 68 (9) 680-684; DOI: 10.1136/jclinpath-2015-203060
False-negative CALR mutation in a suspected myeloproliferative neoplasm: identification, resolution and corrective action
Karl Haslam, Sarah Dell, Emer Atkinson, Helen Enright, Patrick Thornton, Stephen E Langabeer

Journal of Clinical Pathology May 2018, 71 (5) 473-474; DOI: 10.1136/jclinpath-2018-205029
Estimation of cell density to aid in assessment of percentage cells of a particular lineage or of cells expressing a specific antigen in bone marrow trephine biopsies
Saeed Al-Shieban, Paul J Tadrous, Kikkeri N Naresh

Journal of Clinical Pathology Feb 2013, 66 (2) 155-159; DOI: 10.1136/jclinpath-2011-200126
Atypical haematological presentation in a case of polycythaemia vera with a new variant mutation detected in exon 12: c.1605G>T (p.Met535Ile)
Amélia Soraia Andrade Pita, Ana Paula da Silva Azevedo, Alice Reichert, Cândido José Pimenta da Silva, Vanessa Henriques, Diana Sousa Mendes, Ana Maria Batalha Reis, Rita Cerqueira, Fátima Torres, João Faro Viana

Journal of Clinical Pathology Feb 2018, 71 (2) 180-184; DOI: 10.1136/jclinpath-2017-204556
JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing
Etienne Mahe, Kasper Mønsted Pedersen, Yunus Çolak, Stig Egil Bojesen, Tarah Lynch, Gary Sinclair, Faisal Khan, Meer-Taher Shabani-Rad

Journal of Clinical Pathology Feb 2019, 72 (2) 172-176; DOI: 10.1136/jclinpath-2018-205527
The Calreticulin gene and myeloproliferative neoplasms
Aoibhinn Clinton, Mary Frances McMullin

Journal of Clinical Pathology Oct 2016, 69 (10) 841-845; DOI: 10.1136/jclinpath-2016-203899
Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agents
Lanshan Huang, Guillermo Garcia-Manero, Elias Jabbour, Maitrayee Goswami, Mark J Routbort, L Jeffrey Medeiros, Jeffrey L Jorgensen, Sa A Wang

Journal of Clinical Pathology Nov 2016, 69 (11) 1001-1008; DOI: 10.1136/jclinpath-2016-203715
Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms
Jacques A J Malherbe, Kathryn A Fuller, Bob Mirzai, Simon Kavanagh, Chi-Chiu So, Ho-Wan Ip, Belinda B Guo, Cecily Forsyth, Rebecca Howman, Wendy N Erber

Journal of Clinical Pathology Nov 2016, 69 (11) 1017-1024; DOI: 10.1136/jclinpath-2016-203625
Novel germline mutations in the calreticulin gene: implications for the diagnosis of myeloproliferative neoplasms
Natasha Szuber, Bruno Lamontagne, Lambert Busque

Journal of Clinical Pathology Nov 2016, 69 (11) 1033-1036; DOI: 10.1136/jclinpath-2016-203940

Main menu

myeloproliferative disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

myeloproliferative disease

Pages